US2015157702A1PendingUtilityA1
Pneumococcal serotype 6d
Est. expiryMay 29, 2027(~0.8 yrs left)· nominal 20-yr term from priority
A61K 2039/55588C07K 16/1275G01N 2333/3156A61K 39/385A61K 39/092A61K 2039/6031A61K 2039/6081C12Q 1/689C12N 1/20C07K 2317/24C12Q 1/14G01N 33/56944A61P 37/04A61P 31/04C12P 19/04C12R 2001/46C12N 1/205
55
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Disclosed is a new and emerging serotype of Streptococcus pneumoniae designated serotype 6D, and assays and monoclonal antibodies useful in identifying same. Also disclosed is a novel pneumococcal polysaccharide with the repeating unit→2) glucose 1 (1→3) glucose 2 (1→3) rhamnose (1-4) ribitol (5→phosphate. This new serotype may be included in pneumococcal vaccines.
Claims
exact text as granted — not AI-modifiedWe claim:
1 . An isolated bacterial strain designated Streptococcus pneumoniae 6D; said bacterial strain characterized as having a capsular polysaccharide having the repeating unit {→2) glucose 1 (1→3) glucose 2 (1→3) rhamnose (1→4) ribitol (5→phosphate}.
2 . A composition comprising a purified polysaccharide comprising the repeating unit {→2) glucose 1 (1→3) glucose 2 (1→3) rhamnose (1→4) ribitol (5→phosphate}.
3 . The composition of claim 2 , wherein said polysaccharide is conjugated to a carrier.
4 . The composition of claim 2 , wherein the carrier is a protein.
5 . The composition of claim 2 , wherein the carrier is a bead.
6 . The composition of claim 2 , wherein the composition comprises an adjuvant.
7 . The composition of claim 2 , wherein the polysaccharide is produced by a recombinant bacterium that expresses a recombinant genome that produces a capsular polysaccharide having the repeating unit {→2) glucose 1 (1→3) glucose 2 (1→3) rhamnose (1→4) ribitol (5→phosphate}.
8 . The composition of claim 2 , wherein the polysaccharide is produced by an isolated Streptococcus pneumoniae 6D, wherein said Streptococcus pneumoniae 6D has a capsular polysaccharide having the repeating unit {→2) glucose 1 (1→3) glucose 2 (1→3) rhamnose (1→4) ribitol (5→phosphate}.
9 . A method of generating monoclonal or polyclonal antibodies using the composition of claim 2 .
10 . The method of claim 9 , wherein the composition further comprises an adjuvant.
11 . The method of claim 9 , wherein the polysaccharide is conjugated to a carrier.Join the waitlist — get patent alerts
Track US2015157702A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.